PROCTER & GAMBLE COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161.3 USD | -0.78% |
|
+1.99% | +10.07% |
| Apr. 26 | Colgate-Palmolive raises sales growth target after strong Q1 results | RE |
| Apr. 25 | Argus Adjusts Procter & Gamble's Price Target to $185 From $180, Keeps Buy Rating | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analyst opinion has improved significantly over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With a 2024 P/E ratio at 26.12 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +10.07% | 381B | C- | ||
| +14.18% | 74.67B | A+ | ||
| -16.59% | 62.59B | A- | ||
| +0.82% | 52.86B | B+ | ||
| -12.40% | 36.11B | - | ||
| +3.54% | 33.57B | B- | ||
| +7.92% | 17.29B | A- | ||
| +6.30% | 14.75B | B | ||
| -8.65% | 10.82B | C+ | ||
| +12.89% | 9.31B | B |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- PG Stock
- Ratings Procter & Gamble Company
